Pfizer stock forecast
The Pfizer stock forecast, using LSEG data, summarises the latest analyst ratings, price targets, and market sentiment for PFE.
The Pfizer stock forecast, using LSEG data, summarises the latest analyst ratings, price targets, and market sentiment for PFE.
Discover what analysts expect for Pfizer's share price outlook in 2026.
Forecast figures are sourced from LSEG and are for informational purposes only. This is not investment advice. Past performance is not a reliable indicator of future results.
Pfizer analyst ratings (consensus)
Based on 30 analysts, Pfizer (PFE) holds a BUY consensus rating.
- Strong Buy: 13.33%
- Buy: 30%
- Hold: 53.33%
- Sell: 0%
- Strong Sell: 3.33%
If a majority of analysts rate PFE as a Buy or Strong Buy, sentiment is broadly positive. If most analysts rate it Hold, sentiment is neutral, suggesting limited short-term momentum. If Sell or Strong Sell dominates, analysts currently see downside potential. These opinions may change over time and should not be taken as investment advice.
Pfizer stock forecast 2026 and price targets: 12-month outlook
- Highest target for PFE: $37.54
- Lowest target for PFE: $23
- Average target for PFE: $28.85
According to LSEG data, Pfizer share price forecasts indicate a 12-month price range between $23 and $37.54.
Pfizer stock price today
While short-term movements are normal, the average analyst target suggests longer-term expectations towards $28.85.
Past performance is not a reliable indicator of future results.
FAQ
Is Pfizer a good stock to buy?
The current consensus rating is BUY, according to LSEG analyst data.
What is the 12-month PFE stock forecast?
The average 12-month analyst price target for PFE is $28.85, according to aggregated third-party data.
What is the highest PFE price forecast?
The highest 12-month target for PFE (most optimistic) stands at $37.54.
What is the lowest analyst target for PFE?
The most cautious analyst estimate places PFE at $23 over the next year.